FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Regeneron Pharmaceuticals has entered a new manufacturing and supply agreement with Fujifilm Diosynth Biotechnologies.

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

INDIANAPOLIS — Roche, a Swiss biotechnology company whose U.S. headquarters is in Indianapolis, has announced its intention ...

As pharma giants line up one after another to tout their investment plans in the U.S., Regeneron is adopting a different tack ...